Active, not recruitingPhase 4NCT05663892
Drug-Drug Interaction Study in Trans Women Living With HIV
Studying Acquired immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Maple Leaf Research
- Principal Investigator
- Mona Loutfy, MD, MPHMaple Leaf Research
- Intervention
- Biktarvy 50/200/25 Tab(drug)
- Enrollment
- 45 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Maple Leaf Research, Toronto, Ontario, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05663892 on ClinicalTrials.govOther trials for Acquired immunodeficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07298785Peer-led Dynamic Choice HIV Prevention for Women: The Peer-led DCP Pilot StudyUniversity of California, San Francisco
- ENROLLING BY INVITATIONNANCT07192419Promoting Aging and Thriving With HIVIndiana University
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07182838Proof-of-Concept Clinical Pharmacology Trial for HIV Antigen Presentation Therapeutic Biologic MixHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- RECRUITINGNANCT07064785Video-Intervention to Inspire Treatment Adherence for Life for AdolescentsBaylor College of Medicine
- RECRUITINGNANCT06999928Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVIndiana University
- ACTIVE NOT RECRUITINGNANCT07074899Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in PeruFred Hutchinson Cancer Center
- RECRUITINGNANCT06389565Change My Story Task Shifted Mental Health InterventionMassachusetts General Hospital
- ACTIVE NOT RECRUITINGNANCT06913660ALHIV Smartphone Game StudyEmory University